Evonik
Thursday, November 5, 2026

Drug Delivery Day: Designing and developing a successful formulation

Back to workshop overview

Overview

Evonik Health Care is excited to present our full-day Drug Delivery workshop! Focusing on both oral and parenteral technologies, Evonik’s team has created an agenda full of everything you need to know when designing your formulation.

In this one-day workshop, Evonik’s Drug Delivery experts will share their experiences and insights on the discovery and development of oral formulations, long-acting injectables and RNA-based therapies and mRNA vaccines. As a CDMO partner offering end-to-end solutions, Evonik has decades of experience and expertise in every step of the manufacturing process, including route scouting, process development and optimization, purification, isolation, characterization, scale-up, and commercialization.

Key learnings for participants

  • Introduction to capabilities necessary to support oral and parenteral development and manufacturing
  • Understanding how to best use the EUDRAGIT® and EUDRATEC® Technologies for your oral formulations
  • Brief history of long-acting polymeric injectable drug products on the market, including microparticles and implants
  • Custom polymer and lipid synthesis, parenteral drug services for formulations

Agenda

The workshop will start at 08:30 a.m. on Thursday, November 5, 2026, and finish at 4:00 p.m. on the same day. To see the detailed workshop program please click here

8:30 AM | Registration & Breakfast

9: 15 AM | Welcome & Introduction

Tracy Cheavious
Business Development Manager, Evonik Health Care

9: 30 AM | Overview of EUDRAGIT® Oral Excipients

Dr. Irfan Syed
Associate Director, FAS, Evonik Health Care

10 :00 AM | Customized Release With EUDRATEC® Technologies

Dr. Manish Rane
Associate Director, Technical Sales, Evonik Health Care

10:30 AM | Coffee Break & Networking

11:00 AM | EUDRACAP® ready -to-fill Capsules Enhance Functional Performance

Dr. Kamlesh Oza
Head of Technical Sales NA, Formulation & Application Services, Evonik Health Care

11:30 AM | Solubility Enhancement of Poorly Soluble Drugs Using EUDRAGIT® Polymeric Excipient & EUDRATEC®® SoluFlow

Dr. Irfan Syed
Associate Director, FAS, Evonik Health Care

12: 00 PM | Lunch & Networking

1: 00 PM | Long -acting Formulations – Polymeric Microparticles and Implants

Dr. Tom Tice
Senior Director, Strategic and Technical Marketing, Evonik Health Care

2:00 PM | Choosing the Right Bioresorbable Polymer for your Formulation

Dr. Manish Rane
Associate Director, Technical Sales, Evonik Health Care

2: 30 PM | Coffee Break and Networking

3:00 PM | Lipids, Learnings & Future Opportunities

Dr. Zahra Merchant
Project Manager: Innovation Projects, Evonik Health Care

3: 30 PM | LNP Mixing Technologies

Dr. Michael Parr
Director Formulation and Process Development, Evonik Health Care

4:00 PM | Q&A & Wrap Up

Experts

Dr. Thomas R. Tice
Senior Director Technical Global Strategic and Technical Marketing
Evonik Health Care

Vita
Thomas Tice is internationally recognized for his research and product development of complex parenteral, drug delivery dosage forms based on bioabsorbable polymer excipients. He is known for his accomplishments involving injectable, extended-release microparticles made with bioabsorbable lactide/glycolide polymers designed for systemic and local drug delivery. He was a team leader and core inventor to develop the first commercial, injectable, extended-release microparticle product. This product, a one-month LHRH formulation indicated for the treatment of prostate cancer (Decapeptyl® SR), is still on the market today. He has also served on various US Pharmacopeia expert committees for 17 years, and is currently on the General Chapters Dosage Forms Expert Committee and Excipient Joint Committee.

At Evonik, Dr. Tice, provides scientific support to Evonik’s innovation, sales, product development, research, intellectual property and M&A teams. He earned his BSc in Chemistry and PhD in Biophysics from Syracuse University, New York. He held a postdoctoral fellow position at the University of Alabama at Birmingham (UAB) in Microbiology. He holds 48 US patents with many foreign equivalents and has more than 180 publications, presentations, and invited lectures to his credit. He flew experiments on two Space Shuttle flights.
Irfan Syed
Associate Director Formulation & Application Services
Evonik Health Care

Dr. Manish Rane
Associate Director Technical Sales
Evonik Health Care

Dr. Kamlesh Oza
Head of Technical & Formulation and Application Services for North America
Evonik Health Care

Dr. Michael Parr
Director Formulation and Process Development
Evonik Health Care

Vita
Dr. Michael “Mike” Parr joined the Production & Technology team of Evonik’s Health Care business line in 2021 as director of formulations and process development for the Vancouver site. Mike is responsible for leading multifunctional teams and ensuring the successful execution of a portfolio of complex customer-funded development programs as part of the parenteral drug delivery solutions business.

Mike has more than 20 years of experience in the pharmaceutical industry including roles at Sitka Biopharma, CDRD Ventures Inc., Angiotech and Biogen Idec. His areas of expertise include liposomal drug delivery systems, formulation, molecular biology, GLP, GMP activities and clinical development. Mike holds a B.Sc. Honours and Ph.D. in Biochemistry and Molecular Biology from The University of British Columbia in the laboratory of Dr. Pieter Cullis and he completed post-doctoral studies at Harvard Medical School.
Tracy Cheavious
Business Development Manager 
Evonik Health Care

Register now

Details

Participation fee:
Free of charge
City/State:
California
Country:
USA
Seminar language:
English

Venue

The workshop will take place at:
685 Gateway Blvd, South San Francisco, CA 94080

Questions?

Likhitha Bingham
Marketing Analyst
Evonik Health Care
E-Mail
Register now